ACPT-I

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2016
012320042016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
In the present study, we investigated the effect of ACPT-I [(1S, 3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid], a blood… (More)
Is this relevant?
2009
2009
Our earlier studies have demonstrated that (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid ACPT-I, a group III mGlu… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 5
Is this relevant?
2009
2009
Several lines of evidence implicate dysfunction of glutamatergic neurotransmission in opiate dependence and withdrawal… (More)
  • figure 1
  • figure 2
Is this relevant?
2008
2008
Several lines of evidence implicate dysfunction of glutamatergic neurotransmission in the pathophysiology of schizophrenia… (More)
Is this relevant?
2008
2008
Glutamate plays a key role in modulation of nociceptive processing. This excitatory amino acid exerts its action through two… (More)
Is this relevant?
2007
2007
Drugs activating group III metabotropic glutamate receptors (mGluRs) represent therapeutic alternatives to L-DOPA (L-3,4… (More)
Is this relevant?
2007
2007
Literature data have provided evidence that antagonists of group I metabotropic glutamate receptors (mGluRs) and agonists of… (More)
Is this relevant?
2006
2006
Numerous pharmacological data indicate involvement of glutamate, the major excitatory neurotransmitter in the brain, in the… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
2004
2004
It was well established that compounds which decrease glutamatergic transmission via blockade of NMDA or group I mGlu receptors… (More)
Is this relevant?
2004
2004
In islets of Langerhans, L-glutamate is stored in glucagon-containing secretory granules of alpha-cells and cosecreted with… (More)
  • figure 1
  • figure 1
  • table 1
  • figure 2
  • figure 2
Is this relevant?